Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A synthetic sandalwood odorant can boost antimicrobial production in hair follicles, making them more resistant to bacteria.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.

Terbinafine and itraconazole are more effective against Microsporum canis than fluconazole and griseofulvin.

Kerion cases had longer disease duration but responded well to antifungal treatments.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

Using a higher concentration of triamcinolone acetonide leads to faster hair regrowth in scalp patchy alopecia areata.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

Sandalore®, a synthetic scent, reduced hair loss and improved hair growth in women with telogen effluvium.

Transcutol® helps drugs penetrate the skin more effectively in various formulations.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

Allopregnanolone helps control oxytocin levels during pregnancy to prevent preterm labor.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Nanoparticles with more oleic acid improved the delivery and stability of the drug spironolactone.

The new formulation improved the skin absorption of the drug Thiocolchicoside.

Lactiplantibacillus plantarum lysate from green tea may help treat scalp seborrheic dermatitis.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

PUVA treatment is effective and safe for alopecia areata.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.